145 related articles for article (PubMed ID: 8124480)
1. Treatment of growth delay in boys with isolated growth hormone deficiency.
Albanese A; Stanhope R
Eur J Endocrinol; 1994 Jan; 130(1):65-9. PubMed ID: 8124480
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
Albanese A; Kewley GD; Long A; Pearl KN; Robins DG; Stanhope R
Arch Dis Child; 1994 Oct; 71(4):315-7. PubMed ID: 7979523
[TBL] [Abstract][Full Text] [Related]
3. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
Malhotra A; Poon E; Tse WY; Pringle PJ; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1993 Apr; 38(4):393-8. PubMed ID: 8319371
[TBL] [Abstract][Full Text] [Related]
4. Oxandrolone in constitutional delay of growth: analysis of the growth patterns up to final stature.
Bassi F; Neri AS; Gheri RG; Cheli D; Serio M
J Endocrinol Invest; 1993 Feb; 16(2):133-7. PubMed ID: 8463549
[TBL] [Abstract][Full Text] [Related]
5. The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
Schroor EJ; van Weissenbruch MM; Knibbe P; Delemarre-van de Waal HA
Eur J Pediatr; 1995 Dec; 154(12):953-7. PubMed ID: 8801102
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.
Albanese A; Stanhope R
J Pediatr; 1995 Apr; 126(4):545-50. PubMed ID: 7699531
[TBL] [Abstract][Full Text] [Related]
7. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
8. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
Satoh M; Tanaka T; Hibi I
J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency.
Romshe CA; Sotos JF
J Pediatr; 1980 Jan; 96(1):127-31. PubMed ID: 7350292
[TBL] [Abstract][Full Text] [Related]
10. Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.
Papadimitriou A; Wacharasindhu S; Pearl K; Preece MA; Stanhope R
Arch Dis Child; 1991 Jul; 66(7):841-3. PubMed ID: 1863096
[TBL] [Abstract][Full Text] [Related]
11. Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
Clayton PE; Shalet SM; Price DA; Addison GM
Clin Endocrinol (Oxf); 1988 Aug; 29(2):123-30. PubMed ID: 3248354
[TBL] [Abstract][Full Text] [Related]
12. Is testosterone therapy for boys with constitutional delay of growth and puberty associated with impaired final height and suppression of the hypothalamo-pituitary-gonadal axis?
Uruena M; Pantsiotou S; Preece MA; Stanhope R
Eur J Pediatr; 1992 Jan; 151(1):15-8. PubMed ID: 1728537
[TBL] [Abstract][Full Text] [Related]
13. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
Tanner JM; Whitehouse RH; Hughes PC; Carter BS
J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
[TBL] [Abstract][Full Text] [Related]
14. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WH; Holly JM; Shalet SM
Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704
[TBL] [Abstract][Full Text] [Related]
15. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
[TBL] [Abstract][Full Text] [Related]
16. Management of growth hormone deficiency through puberty.
Stanhope R; Uruena M; Hindmarsh P; Leiper AD; Brook CG
Acta Paediatr Scand Suppl; 1991; 372():47-52; discussion 53. PubMed ID: 1927519
[TBL] [Abstract][Full Text] [Related]
17. Management of the short stature due to pubertal delay in boys.
Adan L; Souberbielle JC; Brauner R
J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
[TBL] [Abstract][Full Text] [Related]
18. Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WR; Shalet SM
J Clin Endocrinol Metab; 1995 Jun; 80(6):1869-75. PubMed ID: 7775634
[TBL] [Abstract][Full Text] [Related]
19. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
20. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
